Pharmaceutical Technology

JUNE 19, 2023

UK-based pharmaceutical giant GSK has announced that the US Food and Drug Administration (FDA) has extended the review period of its new drug application (NDA) for the rare bone cancer drug momelotinib by three months. The reason for this review extension was undisclosed in the announcement. people per every 100,000 individuals in the US.

Food and Drug Administration 98

Food and Drug Administration FDA Prescription Food 98

World of DTC Marketing

APRIL 15, 2021

While patients have the right to full disclosure, misinformation and scare tactics could lead to more deaths from COVID. Also cited was a lack of trust in the government to ensure the vaccines’ safety and effectiveness. A big source of mistrust in the COVID-19 vaccine comes from the speed at which it was produced.

Food and Drug Administration 203

Food and Drug Administration Government Safety Side effects 203

pharmaphorum

AUGUST 11, 2022

More than 60 percent of all American adults take prescription drugs , amounting to approximately 131 million individuals. The best way to do that is to target specific sub-populations, which will serve as a natural lead into personalised medicine becoming more mainstream. billion in the United States alone.

Side effects 91

Side effects Medical Prescription Patients 91

pharmaphorum

OCTOBER 27, 2022

Additionally, SeresTx’s BLA has been granted Priority Review designation with a Prescription Drug User Fee Act (PDUFA) target date of 26 th April 2023. In July 2021, Swiss food giant Nestle paid $175 million upfront for North American co-marketing rights to SER-109.

FDA 44

FDA Prescription Food Medical 44

European Pharmaceutical Review

NOVEMBER 15, 2022

As ISPE GAMP 5 Second Edition notes in the preface “Operating in a highly regulated industry may lead practitioners to apply prescriptive and rigid compliance-based approaches that are not commensurate with and not effective in managing any actual risk to the product and the patient.” Takeaways from ISPE’s GAMP 5 Second Edition update.

Manufacturing 83

Manufacturing Pharma Food and Drug Administration Safety 83

PM360

AUGUST 9, 2022

Furthermore, when providers rely on self-reporting, they may be receiving inaccurate data, such that providers may erroneously acknowledge a patient’s filled prescription as evidence of adherence. Measuring and monitoring adherence in clinical trials would add valuable information about the effectiveness and safety of drugs.

Medical 105

Medical Electronics Patients Healthcare 105

Clarify Health

MAY 24, 2023

For the patient, this can lead to improved patient experience, better-informed patient outreach efforts, and a higher-quality care experience overall. After the fact, they also have to navigate obtaining any follow-up referral appointments, filling prescriptions, and paying their bill. Ensuring interoperability.

Patients 52

Patients Healthcare Healthcare Insurance 52